Korea Pharma (South Korea)

455 papers and 6.7k indexed citations

About

In recent decades, authors affiliated with Korea Pharma (South Korea) have published 455 papers, which have received a total of 6.7k indexed citations. Scholars at this organization have produced 103 papers in Molecular Biology, 41 papers in Biomedical Engineering and 38 papers in Surgery on the topics of Inflammatory mediators and NSAID effects (12 papers), Pharmacological Effects of Natural Compounds (11 papers) and Marine Sponges and Natural Products (11 papers). Their work is cited by papers focused on Molecular Biology (1.6k citations), Biomedical Engineering (742 citations) and Materials Chemistry (574 citations). Authors at Korea Pharma (South Korea) collaborate with scholars in South Korea, United States and Japan and have published in prestigious journals including Nucleic Acids Research, Advanced Materials and Journal of Clinical Investigation. Some of Korea Pharma (South Korea)'s most productive authors include Paul Gallo, Michael V. Storm, Timothy M. Dall, Terry R. West, April P. Semilla, Yong Sik Ok, Jongki Hong, Jee H. Jung, Kwang Sik Im and Shi‐Bin Wang.

In The Last Decade

Korea Pharma (South Korea)

395 papers receiving 6.6k citations

Fields of papers published by authors at Korea Pharma (South Korea)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Korea Pharma (South Korea) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Korea Pharma (South Korea) at the time of their publication.

Countries citing scholars working at Korea Pharma (South Korea)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Korea Pharma (South Korea). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Korea Pharma (South Korea) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Korea Pharma (South Korea) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026